Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program
20 juin 2018 08h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, June 20, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...